Rational design of potent sialidase-based inhibitors of influenza virus replication

Cited by (1,001)

Items 901–1,000 of 1,001

1. Characterization of Influenza B Virus Variants with Reduced Neuraminidase Inhibitor Susceptibility
   Rubaiyea Farrukee, Alexander E. Zarebski, James M. McCaw, Jesse D. Bloom, Patrick C. Reading, Aeron C. Hurt · 2018 · Antimicrobial Agents and Chemotherapy
2. The Structure, Function, and Inhibition of Influenza Virus Neuraminidase
   Elspeth F. Garman, Graeme W. Laver · 2007 · Springer eBooks
3. Catalytic mechanism and novel receptor binding sites of human parainfluenza virus type 3 hemagglutinin-neuraminidase (hPIV3 HN)
   Victor A. Streltsov, Patricia A. Pilling, Susan Barrett, Jennifer L. McKimm‐Breschkin · 2015 · Antiviral Research
4. Molecular Recognition of Ligands by Native Viruses and Virus-Like Particles as Studied by NMR Experiments
   Christoph Rademacher, Thomas Peters · 2008 · Topics in current chemistry
5. Aminoglycoside antibiotics bind to the influenza A virus RNA promoter
   Henna Kim, Mi‐Kyung Lee, Junsang Ko, Chin‐Ju Park, Meehyein Kim, Yujeong Jeong, Sungwoo Hong, Gabriele Varani, Byong‐Seok Choi · 2012 · Molecular BioSystems
6. The design, synthesis and biological evaluation of neuraminic acid-based probes of Vibrio cholerae sialidase
   Jennifer C. Wilson, Robin J. Thomson, Jeffrey C. Dyason, Pas Florio, Kaylene J. Quelch, Samia Abo, Mark von Itzstein · 2000 · Tetrahedron Asymmetry
7. Zanamivir in the treatment of influenza
   Douglas Fleming · 2003 · Expert Opinion on Pharmacotherapy
8. Saturation transfer difference (STD) 1H‐NMR experiments and in silico docking experiments to probe the binding of N‐acetylneuraminic acid and derivatives to Vibrio cholerae sialidase
   Thomas Haselhorst, Jennifer C. Wilson, Robin J. Thomson, Sarah McAtamney, John G. T. Menting, Ross L. Coppel, Mark von Itzstein · 2004 · Proteins Structure Function and Bioinformatics
9. A Single Amino Acid Alteration in the Human Parainfluenza Virus Type 3 Hemagglutinin-Neuraminidase Glycoprotein Confers Resistance to the Inhibitory Effects of Zanamivir on Receptor Binding and Neuraminidase Activity
   Matthew T. Murrell, Matteo Porotto, Olga Greengard, Natalia Poltoratskaia, Anne Moscona · 2001 · Journal of Virology
10. Rapid analysis of O-acetylated neuraminic acids by matrix assisted laser desorption/ionization time-of-flight mass spectrometry
    Peer Stehling, Martin Gohlke, Rudolf Fitzner, Werner G. Reutter · 1998 · Glycoconjugate Journal
11. Software for structure-based drug design
    Wayne C. Guida · 1994 · Current Opinion in Structural Biology
12. Taking aim at a moving target — inhibitors of influenza virus Part 2: viral replication, packaging and release
    Nicholas A. Meanwell, Mark Krystal · 1996 · Drug Discovery Today
13. Structures by numbers
    Alison Abbott · 2000 · Nature
14. Detecting and understanding genetic and structural features in HIV-1 B subtype V3 underlying HIV-1 co-receptor usage
    Mengjie Chen, Valentina Svicher, Anna Artese, Giosuè Costa, Claudia Alteri, Francesco Ortuso, Lucia Parrotta, Yang Liu, Chang Liu, Carlo Federico Perno et al. · 2013 · Bioinformatics
15. Biological Activity and Molecular Docking Study of Some Bicyclic Structures: Antidiabetic and Anticholinergic Potentials
    Parham Taslımı, Fidan N. Akhundova, Malahat Kurbanova, Fikret Türkan, Burak Tüzün, Afsun R. Sujayev, Nastaran Sadeghian, Abel Mammadali Maharramov, Vagif Farzaliyev, İlhami Gülçın · 2021 · Polycyclic aromatic compounds
16. Synthesis of potent pyrrolidine influenza neuraminidase inhibitors
    A. Chris Krueger, Yibo Xu, Warren M. Kati, Dale J. Kempf, Clarence J. Maring, Keith F. McDaniel, Akhteruzzaman Molla, Debra Montgomery, William E. Kohlbrenner · 2008 · Bioorganic & Medicinal Chemistry Letters
17. Inhibitors of RNA editing as potential chemotherapeutics against trypanosomatid pathogens
    Reza Salavati, Houtan Moshiri, Smriti Kala, Hamed Shateri Najafabadi · 2011 · International Journal for Parasitology Drugs and Drug Resistance
18. Synthesis, structure and inhibitory activity of a stereoisomer of oseltamivir carboxylate
    Andrea M. Sartori, Luca Dell’Amico, Lucia Battistini, Claudio Curti, Silvia Rivara, Daniele Pala, Philip S. Kerry, Giorgio Pelosi, Giovanni Casiraghi, Gloria Rassu et al. · 2013 · Organic & Biomolecular Chemistry
19. Asymmetric Organocatalysis at the Service of Medicinal Chemistry
    Alfredo Ricci · 2014 · ISRN Organic Chemistry
20. In vitro anti-influenza A activity of interferon (IFN)-λ1 combined with IFN-β or oseltamivir carboxylate
    Natalia A. Ilyushina, Raymond P. Donnelly · 2014 · Antiviral Research
21. Recent advances in pharmacophore modeling and its application to anti-influenza drug discovery
    Woo-Jin Shin, Baik Lin Seong · 2013 · Expert Opinion on Drug Discovery
22. Carbohydrate-mimetic peptides: structural aspects of mimicry and therapeutic implications
    Mark Agostino, Mauro S. Sandrin, Philip Evan Thompson, William Farrugia, Paul A. Ramsland, Elizabeth Yuriev · 2011 · Expert Opinion on Biological Therapy
23. Synthesis of oseltamivir and tamiphosphor from N-acetyl-d-glucosamine
    Chih-An Chen, Jim‐Min Fang · 2013 · Organic & Biomolecular Chemistry
24. Sialic acids as link to Japanese scientists
    Roland Schauer · 2016 · Proceedings of the Japan Academy Series B
25. Combating influenza: natural products as neuraminidase inhibitors
    Nisha Singh, Nawed Anjum, Ramesh Chandra · 2018 · Phytochemistry Reviews
26. Super short membrane-active lipopeptides inhibiting the entry of influenza A virus
    Wenjiao Wu, Jingyu Wang, Dongguo Lin, Linqing Chen, Xiangkun Xie, Xintian Shen, Qingqing Yang, Qiuyi Wu, Jie Wu Yang, Jian G. He et al. · 2015 · Biochimica et Biophysica Acta (BBA) - Biomembranes
27. Evolution of Influenza Neuraminidase and the Detection of Antiviral Resistant Strains Using Mass Trees
    Kavya Swaminathan, Kevin M. Downard · 2013 · Analytical Chemistry
28. Aglycone-focused randomization of 2-difluoromethylphenyl-type sialoside suicide substrates for neuraminidases
    Hirokazu Kai, Hiroshi Hinou, Shin‐Ichiro Nishimura · 2012 · Bioorganic & Medicinal Chemistry
29. Synthetic Routes to Three Novel Scaffolds for Potential Glycosidase Inhibitors
    Michael Rommel, Alexander Ernst, Ulrich Koert · 2007 · European Journal of Organic Chemistry
30. Contribution of the Human Parainfluenza Virus Type 3 HN-Receptor Interaction to Pathogenesis In Vivo
    Gregory A. Prince, Martin G. Ottolini, Anne Moscona · 2001 · Journal of Virology
31. Mutation of Neuraminidase Cysteine Residues Yields Temperature-Sensitive Influenza Viruses
    Christopher F. Basler, Adolfo García‐Sastre, Peter Palese · 1999 · Journal of Virology
32. QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR
    Mingyue Zheng, Kunqian Yu, Hong Liu, Xiaomin Luo, Kaixian Chen, Weiliang Zhu, Hualiang Jiang · 2006 · Journal of Computer-Aided Molecular Design
33. Versatile Functionalization of Carbohydrate Hydroxyl Groups through Their O-Cyanomethyl Ethers
    Carles Malet, Ole Hindsgaul · 1996 · The Journal of Organic Chemistry
34. Reduced levels of neuraminidase of influenza A viruses correlate with attenuated phenotypes in mice
    Alicia Solórzano, Ervin Fodor, George G. Brownlee, Peter Palese, Hongyong Zheng, Adolfo García‐Sastre · 2000 · Journal of General Virology
35. Synthesis of 3-episiastatin B analogues having anti-influenza virus activity.
    Yoshio Nishimura, Yōji Umezawa, Shinichi Kondo, TOMIO TAKEUCHI, KEIJI MORI, Isao Kijima‐Suda, Kenkichi Tomita, Kanetsu Sugawara, Kiyoto Nakamura · 1993 · The Journal of Antibiotics
36. Chemoprophylaxis of Influenza A Virus Infections, with Single Doses of Zanamivir, Demonstrates that Zanamivir Is Cleared Slowly from the Respiratory Tract
    Robert J. Fenton, Peter J. Morley, Ian J. Owens, David Gower, Simon Parry, Lee Crossman, Tony Wong · 1999 · Antimicrobial Agents and Chemotherapy
37. The Biology of Sialic Acids: Insights into their Structure, Metabolism and Function in Particular during Viral Infection
    Werner G. Reutter, Roger Stäsche, Peer Stehling, Oliver Baum · 1996
38. WaterKit: Thermodynamic Profiling of Protein Hydration Sites
    Jérôme Eberhardt, Stefano Forli · 2023 · Journal of Chemical Theory and Computation
39. Structure of an Influenza A virus N9 neuraminidase with a tetrabrachion-domain stalk
    Victor A. Streltsov, Peter M. Schmidt, Jennifer L. McKimm‐Breschkin · 2019 · Acta Crystallographica Section F Structural Biology Communications
40. Indian Guidelines on Nebulization Therapy
    S K Katiyar, Shailendra N. Gaur, RN Solanki, Nikhil Sarangdhar, Jagdish Chander Suri, Raj Kumar, GC Khilnani, Dhruva Chaudhary, Rupak Singla, Parvaiz Ahmad Koul et al. · 2022 · Indian Journal of Tuberculosis
41. Plant Metabolites as SARS-CoV-2 Inhibitors Candidates: In Silico and In Vitro Studies
    Alberto Jorge Oliveira Lopes, Gustavo Pereira Calado, Yuri Nascimento Fróes, Sandra Alves de Araújo, Lucas Martins França, Antonio Marcus de Andrade Paes, Sebastião Vieira de Morais, Claúdia Quintino da Rocha, Cleydlenne Costa Vasconcelos · 2022 · Pharmaceuticals
42. Emerging antiviral therapies and drugs for the treatment of influenza
    Jinshen Wang, Yihang Sun, Shuwen Liu · 2022 · Expert Opinion on Emerging Drugs
43. N-Alkylated aziridines are easily-prepared, potent, specific and cell-permeable covalent inhibitors of human β-glucocerebrosidase
    B. T. Adams, Sarah Niccoli, M. A. Chowdhury, A. N. K. Esarik, Simon James Lees, Brian P. Rempel, Christopher P. Phenix · 2015 · Chemical Communications
44. Absence of Pharmacokinetic Interaction Between Intravenous Peramivir and Oral Oseltamivir or Rimantadine in Humans
    George J. Atiee, Kenneth C. Lasseter, Sharon Baughman, Amy J McCullough, Phil Collis, Alan S. Hollister, Jaime E. Hernández · 2011 · The Journal of Clinical Pharmacology
45. Prolidase Is Required for Early Trafficking Events during Influenza A Virus Entry
    Marie O. Pohl, Thomas O. Edinger, Silke Stertz · 2014 · Journal of Virology
46. Rational design of Tamiflu derivatives targeting at the open conformation of neuraminidase subtype 1
    Yan Li, Bingcheng Zhou, Renxiao Wang · 2009 · Journal of Molecular Graphics and Modelling
47. Integration of neuraminidase inhibitor assay into a single-step operation using a combinable poly(dimethylsiloxane) capillary sensor
    Tadashi Ishimoto, Kaede Jigawa, Terence G. Henares, Tatsuro Endo, Hideaki Hisamoto · 2013 · The Analyst
48. Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus
    Charlotte Ryan, Viateslav Zaitsev, David J. Tindal, Jeffrey C. Dyason, Robin J. Thomson, Irina V. Alymova, Allen Portner, Mark von Itzstein, Garry L. Taylor · 2006 · Glycoconjugate Journal
49. Quantitative Predictions of Binding Free Energy Changes in Drug-Resistant Influenza Neuraminidase
    Daniel R. Ripoll, Ilja V. Khavrutskii, Sidhartha Chaudhury, Jin Liu, Robert A. Kuschner, Anders Wallqvist, Jaques Reifman A · 2012 · PLoS Computational Biology
50. Nucleophilic Substitution Reactions of Pyranose Polytosylates
    Ross P. McGeary, Sara Rasoul Amini, Vincent W. S. Tang, István Tóth · 2004 · The Journal of Organic Chemistry
51. The current structural glycome landscape and emerging technologies
    Liviu Copoiu, Sony Malhotra · 2020 · Current Opinion in Structural Biology
52. Computational design of novel, high-affinity neuraminidase inhibitors for H5N1 avian influenza virus
    Jin‐Woo Park, Won Ho Jo · 2009 · European Journal of Medicinal Chemistry
53. Exposing the Flexibility of Human Parainfluenza Virus Hemagglutinin-neuraminidase
    Moritz Winger, Mark von Itzstein · 2012 · Journal of the American Chemical Society
54. The old pharmaceutical oleoresin labdanum of Cistus creticus L. exerts pronounced in vitro anti-dengue virus activity
    Kenny Kuchta, Nguyễn Hữu Tùng, Tomoe Ohta, Takuhiro Uto, Muhareva Raekiansyah, Kristina Grötzinger, Hans Rausch, Yukihiro Shoyama, Hans Wilhelm Rauwald, Kouichi Morita · 2019 · Journal of Ethnopharmacology
55. A Synthesis of Tamiflu by Using a Barium‐Catalyzed Asymmetric Diels–Alder‐Type Reaction
    Kenzo Yamatsugu, Liang Yin, Shin Kamijo, Yasuaki Kimura, Motomu Kanai, Masakatsu Shibasaki · 2008 · Angewandte Chemie
56. Influenza Neuraminidase as Target for Antivirals
    Gillian M. Air, Anita A. Ghate, Stephen J. Stray · 1999 · Advances in virus research
57. Review: Anti-infectives Recent developments in the antiviral therapy of influenza
    Andrew R. Whittington, Richard C. Bethell · 1995 · Expert Opinion on Therapeutic Patents
58. Antiviral Drugs for Influenza: Tamiflu ® Past, Present and Future
    Graeme W. Laver · 2006 · Future Virology
59. Influenza Viruses and Cell Membranes
    John James Skehel, Don C. Wiley · 1995 · American Journal of Respiratory and Critical Care Medicine
60. A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community
    JOHN S. OXFORD · 2004 · Journal of Antimicrobial Chemotherapy
61. Zanamivir, a New Targeted Therapy in the Treatment of Influenza
    Chris A. Silagy, Richard W. Watts · 2000 · Clinical Drug Investigation
62. Methods of Glycoconjugate Analysis
    Elizabeth F. Hounsell · 1996
63. 4-Guanidino-Neu5Ac2en fails to protect chickens from infection with highly pathogenic avian influenza virus
    John W. McCauley, L. A. Pullen, Morag A. Forsyth, Charles R. Penn, G.P. Thomas · 1995 · Antiviral Research
64. Implications of Antiviral Resistance of Influenza Viruses
    Arnold S. Monto · 2009 · Clinical Infectious Diseases
65. GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review
    De Masi, Roberto, Orlando, Stefania · 2022 · International Journal of Molecular Sciences
66. Sequence diversity of NanA manifests in distinct enzyme kinetics and inhibitor susceptibility
    Zhongli Xu, Susanne von Grafenstein, Elisabeth Walther, Julian E. Fuchs, Klaus Roman Liedl, Andreas Sauerbrei, Michaela Schmidtke · 2016 · Scientific Reports
67. Bacterial neuraminidase inhibition by phenolic compounds from Usnea longissima
    Mahboob Ullah, Zia Uddin, Yeong Hun Song, Z.P. Li, Jeong Yoon Kim, Younglan Ban, Ki Hun Park · 2018 · South African Journal of Botany
68. Computational and Pharmacogenomic Insights on Hypertension Treatment: Rational Drug Design and Optimization Strategies
    Lakshmanan Loganathan, Krishnasamy Gopinath, Vadivel Murugan Sankaranarayanan, Ritushree Kukreti, Kannan Rajendran, Jung-Kul Lee, Karthikeyan Muthusamy · 2019 · Current Drug Targets
69. Decoupling of catalysis and transition state analog binding from mutations throughout a phosphatase revealed by high-throughput enzymology
    Craig James Markin, Daniel Alexander Mokhtari, Siyuan Du, Tzanko I. Doukov, Fanny Sunden, Jordan A. Cook, Polly Morrell Fordyce, Daniel Herschlag · 2023 · Proceedings of the National Academy of Sciences
70. The de-guanidinylated derivative of peramivir remains a potent inhibitor of influenza neuraminidase
    Caleb M. Bromba, Jeremy W. Mason, Michael G. Brant, Tracy Chan, Martine D. Lunke, Martin Petric, Martin J. Boulanger, Jeremy E. Wulff · 2011 · Bioorganic & Medicinal Chemistry Letters
71. Permeability Enhancers Dramatically Increase Zanamivir Absolute Bioavailability in Rats: Implications for an Orally Bioavailable Influenza Treatment
    Eric H. Holmes, Harikrishna Devalapally, Libin Li, Michael L. Perdue, Gary K. Ostrander · 2013 · PLoS ONE
72. Concise synthesis of zanamivir and its C4-thiocarbamido derivatives utilizing a [3+2]-cycloadduct derived from d-glucono-δ-lactone
    Xue-Bin Zhu, Meng Wang, Shaozhong Wang, Zhu‐Jun Yao · 2012 · Tetrahedron
73. Neuraminidase Resistant Sialosides for the Detection of Influenza Viruses
    Yun He, Yang Yang, Suri S. Iyer · 2016 · Bioconjugate Chemistry
74. In vitro evaluation of the antiviral activity of methylglyoxal against influenza B virus infection
    Siriwan Charyasriwong, Takahiro Haruyama, Nobuyuki Kobayashi · 2016 · Drug Discoveries & Therapeutics
75. Efficient immobilization of AGE and NAL enzymes onto functional amino resin as recyclable and high-performance biocatalyst
    Jian Cheng, Wei Zhuang, Chenglun Tang, Yong Chen, Jinglan Wu, Ting Guo, Hanjie Ying · 2016 · Bioprocess and Biosystems Engineering
76. Multivalent zanamivir-bovine serum albumin conjugate as a potent influenza neuraminidase inhibitor
    Tengfei Zhao, Haijuan Qin, Yao Yu, Mei-Bing Yang, Hao Chang, Na Guo, Yun He, Yang Yang, Peng Yu · 2017 · Journal of Carbohydrate Chemistry
77. Alternative Experimental Models for Studying Influenza Proteins, Host–Virus Interactions and Anti-Influenza Drugs
    Sonja C. J. H. Chua, Hui Qing Tan, David Engelberg, Lina H. K. Lim · 2019 · Pharmaceuticals
78. Therapeutic targets for enterovirus infections
    Mira Laajala, Dhanik Reshamwala, Varpu Marjomäki · 2020 · Expert Opinion on Therapeutic Targets
79. Zanamivir–Cholesterol Conjugate: A Long-Acting Neuraminidase Inhibitor with Potent Efficacy against Drug-Resistant Influenza Viruses
    Xun Lv, Pengfei Wang, Chenning Li, Shuihong Cheng, Yuhai Bi, Xuebing Li · 2021 · Journal of Medicinal Chemistry
80. Neuraminidase inhibitors as antivirals
    Peter M. Colman · 2002 · Vaccine
81. New Anti-influenza Agents, FR198248 and Its Derivatives. II. Characterization of FR198248, Its Related Compounds and Some Derivatives.
    Yutaka Nishihara, SFFIGEHIRO TAKASE, Eisaku Tsujii, Hiroshi Hatanaka, SEUI HASHIMOTO · 2001 · The Journal of Antibiotics
82. Conduramine F-1 epoxides: synthesis and their glycosidase inhibitory activities
    Robert Łysek, Sylvain Favre, Pierre Vogel · 2007 · Tetrahedron
83. FADB: a food additive molecular database forin silicoscreening in food toxicology
    Tiziana Ginex, Francesca Spyrakis, Pietro Cozzini · 2014 · Food Additives & Contaminants Part A
84. Electrochemical Studies of the Neuraminidase Inhibitor Zanamivir and its Voltammetric Determination in Spiked Urine
    Sławomira Skrzypek · 2010 · Electroanalysis
85. N-Acetyl-6-sulfo-d-glucosamine as a promising mimic of N-Acetyl neuraminic acid
    Kenji Sasaki, Yoshihiro Nishida, Hirotaka Uzawa, Kazukiyo Kobayashi · 2003 · Bioorganic & Medicinal Chemistry Letters
86. Label-free electrochemical detection of neuraminidase activity: A facile whole blood diagnostic probe for infectious diseases
    Ahmad Zaki Mubarok, Veerappan Mani, Chih‐Hung Huang, Pu-Chieh Chang, Sheng‐Tung Huang · 2017 · Sensors and Actuators B Chemical
87. Matching of Chemical and Biological Structures Using Subgraph and Maximal Common Subgraph Isomorphism Algorithms
    Peter Willett · 1999 · The IMA volumes in mathematics and its applications
88. Synthesis and inhibitory properties of a thiomethylmercuric sialic acid with application to the X-ray structure determination of 9-O-acetylsialic acid esterase from influenza C virus
    Wolfgang Fitz, Peter B. Rosenthal, Chi‐Huey Wong · 1996 · Bioorganic & Medicinal Chemistry
89. Development of inhibitors as research tools for carbohydrate-processing enzymes
    T.M. Gloster · 2012 · Biochemical Society Transactions
90. Evaluation of short-range interactions as secondary structure energies for protein fold and sequence recognition
    Sanzo Miyazawa, Robert L. Jernigan · 1999 · Proteins Structure Function and Bioinformatics
91. Synthesis of 3-substituted isofagomine analogues using an unusual syn hydrogenation reaction
    Anders Lohse, Henrik Helligsø Jensen, Peter Bach, Mikael Bols · 2000 · Journal of the Chemical Society Perkin Transactions 1
92. A facile synthesis of a useful 5-N-substituted-3,5-dideoxy-d-glycero-d-galacto-nonulosonic acid from 2-acetamido-2-deoxy-d-glucose
    Wen-Yang Wu, Betty Jin, David C. M. Kong, Mark von Itzstein · 1997 · Carbohydrate Research
93. SGC - Structural Biology and Human Health: A New Approach to Publishing Structural Biology Results
    Wen Hwa Lee, Julián Atienza-Herrero, Ruben A Abagyan, Brian D. Marsden · 2009 · PLoS ONE
94. Approaches and Strategies for the Treatment of Influenza Virus Infections
    Joseph M. Colacino, Kirk A. Staschke, William Graeme Laver · 1999 · Antiviral chemistry & chemotherapy
95. Drug–Fc conjugate CD388 targets influenza virus neuraminidase and is broadly protective in mice
    Simon Döhrmann, James M Levin, Jason N. Cole, Allen Borchardt, Karin Amundson, Amanda L. Almaguer, Elizabeth Abelovski, Rajvir Grewal, Douglas E. Zuill, Nicholas Dedeic et al. · 2025 · Nature Microbiology
96. In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain
    Syed Hussain Basha, R Nalini Prasad · 2012 · BMC Research Notes
97. In silico and in vitro screening to identify structurally diverse non-azole CYP51 inhibitors as potent antifungal agent
    Aarti Singh, Sarvesh Paliwal, Mukta Sharma, Anupama Mittal, Swapnil K. Sharma, Jai Prakash Sharma · 2015 · Journal of Molecular Graphics and Modelling
98. Residue-based pharmacophore approaches to study protein–protein interactions
    Rojan Shrestha, Jorge Eduardo Fajardo, András Fiser · 2021 · Current Opinion in Structural Biology
99. Binding mechanism of oseltamivir and influenza neuraminidase suggests perspectives for the design of new anti-influenza drugs
    Jiaye Tao, Heping Wang, Wenjian Wang, Na Mi, Wei Zhang, Qiujia Wen, Jiajing Ouyang, Xinyun Liang, Min Chen, Wentao Guo et al. · 2022 · PLoS Computational Biology
100. Recent trends and challenges on carbohydrate-based molecular scaffolding: general consideration toward impact of carbohydrates in drug discovery and development
     Mishra, Nidhi, Tiwari, Vinod K., Schmidt, Richard R. · 2020 · Carbohydrates in Drug Discovery and Development